No increased hemorrhage risk with concurrent tamoxifen, oral anticoagulants - medwireNews

Concurrent use of tamoxifen with a direct oral anticoagulant is not associated with an increased risk for major hemorrhage compared with concurrent use of aromatase inhibitors in people with breast cancer, research suggests.

medwireNews: Concurrent use of tamoxifen with a direct oral anticoagulant (DOAC) is not associated with an increased risk for major hemorrhage compared with concurrent use of aromatase inhibitors (AI… [+2483 chars]

full article...